AbstractTuberculosisA model-guided weight-banded dosing strategy for once daily delamanid in childrenView Abstract
AbstractTuberculosisA model-based analysis of bedaquiline-related QTcF prolongation in the PROBeX studyView Abstract
AbstractTuberculosisA Population Pharmacokinetic Model of Linezolid enabling Model-Informed Precision Dosing in Resistant Tuberculosis PatientsView Abstract
AbstractTuberculosisCerebrospinal Fluid Concentrations of New and Repurposed Drugs among Patients with Tuberculosis MeningitisView Abstract
AbstractTuberculosisEvaluating the effect of clofazimine against Mycobacterium tuberculosisView Abstract
AbstractTuberculosisExposure-response relationship for bedaquiline, delamanid, and their metabolitesView Abstract
AbstractTuberculosisInvestigating the treatment shorting potential of sutezolid-containing regimens in a murine model with confirmed drug exposuresView Abstract
AbstractTuberculosisOperational Challenges with Centralising PK Bioanalysis in a Multicentre Multinational Randomised Controlled TrialView Abstract
AbstractTuberculosisOptimized loading period strategies for bedaquiline at the restart of drug-resistant tuberculosis treatmentView Abstract
AbstractTuberculosisPentamidine shows promising activity against M. tuberculosis and M. avium complex but not M. abscessusView Abstract
AbstractTuberculosisPharmacokinetics of linezolid in Indian patients with multidrug-resistant tuberculosisView Abstract
AbstractTuberculosisPharmacokinetics of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African ChildrenView Abstract
AbstractTuberculosisPopulation pharmacokinetics of cycloserine, administered as terizidone, in South African children treated for rifampicin-resistant tuberculosis.View Abstract
AbstractTuberculosisPopulation Pharmacokinetic Modeling of Pretomanid Dispersible-Tablet Formulation in Healthy VolunteersView Abstract
AbstractTuberculosisPravastatin pharmacokinetics when administered simultaneously with first-line tuberculosis treatmentView Abstract
AbstractTuberculosisRifampin Urine Colorimetry for Evaluation of Tuberculosis PharmacokineticsView Abstract
AbstractTuberculosisSimulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapyView Abstract
AbstractTuberculosisIncidence and determinants of linezolid toxicity in patients with drug-resistant tuberculosis in a high HIV prevalence settingView Abstract
AbstractTuberculosisConcentration-QTcF modelling and drug-drug interaction of Bedaquiline, Pretomanid and Clofazimine in TB patients.View Abstract
